Multiple Sclerosis Clinical Trials in Los Angeles

Showing 481-489 of 489 trials

ALIMTA(Pemetrexed)/Cisplatin and ALIMTA(Pemetrexed)/Carboplatin in Extensive Stage Small Cell Lung Cancer.

NCT00051506

The purpose of this study is to evaluate the effects (good and bad) of ALIMTA plus Carboplatin or ALIMTA plus Cisplatin on you and your small cell lung cancer.

Lung Neoplasms

Eli Lilly and Company

Springdale, Arkansas, United States • Los Angeles, California, United States • Fort Myers, Florida, United States +5 more locations

COMPLETEDPhase 3< 1 mile

A Phase 3 Trial of ALIMTA (LY231514, Pemetrexed) Plus GEMZAR Versus GEMZAR in Patients With Unresectable or Metastatic Cancer of the Pancreas.

NCT00035035

Definition: This study will compare the drug GEMZAR to a combination of GEMZAR plus ALIMTA for the treatment of cancer of the pancreas. Patients may be able to participate in this study if they have cancer in their pancreas that cannot be removed by surgery OR that has spread to a new site in their body.

Pancreatic NeoplasmsMetastases, Neoplasm

Eli Lilly and Company

Huntsville, Alabama, United States • Fountain Valley, California, United States • Fullerton, California, United States +111 more locations

ALIMTA(Pemetrexed)/Cisplatin and ALIMTA(Pemetrexed)/Carboplatin in Extensive Stage Small Cell Lung Cancer.

A Phase 3 Trial of ALIMTA (LY231514, Pemetrexed) Plus GEMZAR Versus GEMZAR in Patients With Unresectable or Metastatic Cancer of the Pancreas.

Multiple Sclerosis Trials in Other Cities

Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer

Tezacitabine and Oxaliplatin for the Treatment of Patients With Metastatic Colorectal Cancer

Study of T900607-Sodium in Previously Treated Patients With Ovarian Cancer.

D-MPH in the Treatment of Fatigue and Neurobehavioral Function Related to Chemotherapy in Adult Cancer Patients

A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer.

Optic Neuritis Treatment Trial (ONTT)

Study of 111In-DAC as an Medical Imaging Agent for Lung Cancer and Brain Cancer Consistent With Metastatic Lung Cancer

Other Conditions in Los Angeles